Commentary: but what should journals actually do to keep industry sponsored research unbiased?BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c5406 (Published 12 October 2010) Cite this as: BMJ 2010;341:c5406
- Chris Del Mar, professor of primary care research
- 1Bond University, Gold Coast, Queensland 4229, Australia
A timely paper from Robert Steinbrook and Jerome P Kassirer (doi:10.1136/bmj.c5391) takes the position that journals should increase the rigour required to address bias in data offered for publication from industry sponsored trials. In particular (1) the definition (currently ambiguous) of “full access to data” for the authors should be cleared up; (2) one author in the team should be truly independent of any pecuniary interest in the product and act as guarantor; (3) data must be available to editors in case of future concern, (something hopefully rarely exercised); and finally (4) there would be consequences after publication if data were found to have been …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial